Despite Synchronoss Technologies' share surge, its low P/S ratio persists due to predicted revenue decline. Its poor outlook, contrasting with industry peers' growth forecasts, justifies the low P/S ratio. Without significant change, a drastic stock price rise seems unlikely.
Rendino believes that SNCR is undervalued and will grow after the sale of non-core assets and extension of its contract with Verizon. Synchronoss CEO and Founder think Kevin's financial expertise could guide the company to sustainable, profitable growth.
Synchronoss Technologies' revised revenue forecast signals pessimism for the next year. Its projected sales drop contrasts the industry's expected 12% annual growth, raising investor caution about its future performance.
Synchronoss Technologies' future remains uncertain due to its disappointing revenue forecast and plummeting share price. Limited growth expectations contribute to its low price-to-sales ratio, and without clear signs of revenue enhancement, share price growth appears unlikely.
Gapping up In reaction to earnings/guidance: •$索尔工业(THO.US)$+2.5% Other news: •$Acumen Pharmaceuticals(ABOS.US)$+76.8% (in response with BIIB) •$渤健公司(BIIB.US)$+45.6% (reports Lecanemab confirmatory Phase 3 Clarity AD study met primary endpoint) •$Nano X Imaging(NNOX.US)$+22.8% (submitted a 510(k) premarket notification to the FDA on Sept 26 for its multisource 3D digital tomosynthesis system) •$Ocugen(OCGN.US)$+9.3% (en...
“Our global customers have specific requirements when it comes to performance, cost, compliance, and critically, data sovereignty,” said Patrick Doran, Chief Technology Officer at Synchronoss. “By extending Personal Cloud on Alibaba and Email Suite on Google Cloud, Synchronoss is able to deliver secure, cost-optimized, in-country solutions that are reliable and scalable, upholding our strategy of supporting hybrid and multiple clou...
Synchronoss Technologies股票讨论区
like
Watch this for sudden volume and bid/ask gap to close
👀
专栏Today's Pre-Market Stock Movers: AAPL, BIIB, OCGN, MNMD and More
In reaction to earnings/guidance:
• $索尔工业(THO.US)$ +2.5%
Other news:
• $Acumen Pharmaceuticals(ABOS.US)$+76.8% (in response with BIIB)
• $渤健公司(BIIB.US)$ +45.6% (reports Lecanemab confirmatory Phase 3 Clarity AD study met primary endpoint)
• $Nano X Imaging(NNOX.US)$+22.8% (submitted a 510(k) premarket notification to the FDA on Sept 26 for its multisource 3D digital tomosynthesis system)
• $Ocugen(OCGN.US)$ +9.3% (en...
专栏Today's pre-market stock movers: RBLX, TTD, VLD, WYNN and more
In reaction to earnings/guidance:
• $The Trade Desk(TTD.US)$+17%,$Workiva(WK.US)$ +15.3%,$Arlo Technologies(ARLO.US)$ +12%,$Array Technologies(ARRY.US)$ +10.3%,$Everbridge(EVBG.US)$ +9.7%,$Catalyst Pharmaceuticals(CPRX.US)$ +9.4%,$奥洛兹美医疗(HALO.US)$ +8.7%,$Velo3D(VLD.US)$ +7.6%,$CyberArk(CYBR.US)$ + 6.2%,$美国血液技术(HAE.US)$ +5.8%,$Jackson Financial(JXN.US)$ +5.7% (also increases dividend),$Axon Enterprise(AXON.US)$ +4.8%,...
Synchronoss Expands Platform Support for Alibaba and Google Cloud
暂无评论